JP2011517673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517673A5 JP2011517673A5 JP2011501963A JP2011501963A JP2011517673A5 JP 2011517673 A5 JP2011517673 A5 JP 2011517673A5 JP 2011501963 A JP2011501963 A JP 2011501963A JP 2011501963 A JP2011501963 A JP 2011501963A JP 2011517673 A5 JP2011517673 A5 JP 2011517673A5
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- inhibitor
- hydrogen
- alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3996108P | 2008-03-27 | 2008-03-27 | |
| US61/039,961 | 2008-03-27 | ||
| PCT/US2009/038010 WO2009120650A1 (en) | 2008-03-27 | 2009-03-24 | Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011517673A JP2011517673A (ja) | 2011-06-16 |
| JP2011517673A5 true JP2011517673A5 (cg-RX-API-DMAC10.html) | 2012-05-10 |
Family
ID=40810527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011501963A Pending JP2011517673A (ja) | 2008-03-27 | 2009-03-24 | 芳香族ヘテロ環縮合インドロベンザジアゼピンｈｃｖｎｓ５ｂ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8431568B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2278977B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2011517673A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20100124848A (cg-RX-API-DMAC10.html) |
| CN (1) | CN101980711B (cg-RX-API-DMAC10.html) |
| AT (1) | ATE531373T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2009228451A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2374870T3 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2010010060A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2009120650A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103288828A (zh) * | 2012-02-24 | 2013-09-11 | 中国科学院大连化学物理研究所 | 一种合成手性二氢-6H-吲哚并[2,1-c][1,4]-苯并二氮杂卓的方法 |
| CN103539723A (zh) * | 2013-10-29 | 2014-01-29 | 南方医科大学 | 一种3-氨基-2-芳甲酰基-1h-吲哚类衍生物的合成方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897392A (en) * | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| WO2005080399A1 (ja) | 2004-02-24 | 2005-09-01 | Japan Tobacco Inc. | ４環縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用 |
| US7153848B2 (en) * | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| US7348425B2 (en) | 2004-08-09 | 2008-03-25 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
| RU2007119562A (ru) | 2004-10-26 | 2008-12-10 | Институто Ди Ричерке Ди Биолоджиа Молеколаре П Анджелетти Спа (It) | Тетрациклические производные индолов в качестве противовирусных агентов |
| GB0518390D0 (en) | 2005-09-09 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| US7473688B2 (en) | 2005-09-13 | 2009-01-06 | Bristol-Myers Squibb Company | Indolobenzazepine HCV NS5B inhibitors |
| US7456165B2 (en) | 2006-02-08 | 2008-11-25 | Bristol-Myers Squibb Company | HCV NS5B inhibitors |
| GB0608928D0 (en) * | 2006-05-08 | 2006-06-14 | Angeletti P Ist Richerche Bio | Therapeutic agents |
| DE602007006796D1 (de) | 2006-05-25 | 2010-07-08 | Bristol Myers Squibb Co | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b-hemmer |
| WO2007140200A2 (en) | 2006-05-25 | 2007-12-06 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| US7452876B2 (en) | 2006-06-08 | 2008-11-18 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| PE20081113A1 (es) * | 2006-07-20 | 2008-10-03 | Genelabs Tech Inc | Inhibidores virales policiclicos |
| US7652004B2 (en) | 2007-08-09 | 2010-01-26 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US7642251B2 (en) | 2007-08-09 | 2010-01-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8143243B2 (en) | 2007-08-09 | 2012-03-27 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8138171B2 (en) | 2008-03-27 | 2012-03-20 | Bristol-Myers Squibb Company | Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
| US8133884B2 (en) | 2008-05-06 | 2012-03-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
-
2009
- 2009-03-24 AT AT09725965T patent/ATE531373T1/de active
- 2009-03-24 MX MX2010010060A patent/MX2010010060A/es active IP Right Grant
- 2009-03-24 ES ES09725965T patent/ES2374870T3/es active Active
- 2009-03-24 CN CN2009801109761A patent/CN101980711B/zh not_active Expired - Fee Related
- 2009-03-24 JP JP2011501963A patent/JP2011517673A/ja active Pending
- 2009-03-24 KR KR1020107023917A patent/KR20100124848A/ko not_active Withdrawn
- 2009-03-24 US US12/922,801 patent/US8431568B2/en active Active
- 2009-03-24 EP EP09725965A patent/EP2278977B1/en not_active Not-in-force
- 2009-03-24 AU AU2009228451A patent/AU2009228451A1/en not_active Abandoned
- 2009-03-24 WO PCT/US2009/038010 patent/WO2009120650A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010515752A5 (cg-RX-API-DMAC10.html) | ||
| JP2010521481A5 (cg-RX-API-DMAC10.html) | ||
| JP2010521476A5 (cg-RX-API-DMAC10.html) | ||
| JP2010521484A5 (cg-RX-API-DMAC10.html) | ||
| JP2010521482A5 (cg-RX-API-DMAC10.html) | ||
| JP2010521483A5 (cg-RX-API-DMAC10.html) | ||
| JP2012504632A5 (cg-RX-API-DMAC10.html) | ||
| JP2013521279A5 (cg-RX-API-DMAC10.html) | ||
| HRP20110194T1 (hr) | Ciklopropil fuzionirani indolobenzazepini kao inhibitori hcv ns5b | |
| JP2013514359A5 (cg-RX-API-DMAC10.html) | ||
| JP2012512169A5 (cg-RX-API-DMAC10.html) | ||
| WO2005077969A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
| DE602004023924D1 (en) | Ease-hemmer | |
| WO2004113365A3 (en) | Hepatitis c serine protease tri-peptide inhibitors | |
| JP2012513479A5 (cg-RX-API-DMAC10.html) | ||
| MX2010006210A (es) | Inhibidores de serina proteasa de hcv de tripeptido fluorado. | |
| WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| JP2011523651A5 (cg-RX-API-DMAC10.html) | ||
| JP2010532352A5 (cg-RX-API-DMAC10.html) | ||
| WO2008002924A3 (en) | Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors | |
| WO2009053828A3 (en) | P3 hydroxyamino macrocyclic hepatitis c serine protease inhibitors | |
| MY146123A (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatment using the same | |
| JP2005529069A5 (cg-RX-API-DMAC10.html) |